Imaging of recurrent prostate cancer
SourceRadiologic Clinics of North America, 50, (2012), pp. 1075-1083
Article / Letter to editor
Display more detailsDisplay less details
Radiologic Clinics of North America
SubjectNCEBP 14: Cardiovascular diseases; NCEBP 14: Cardiovascular diseases ONCOL 5: Aetiology, screening and detection
Approximately 30\% of patients who underwent radical prostatectomy or radiation therapy will develop biochemical recurrent disease. Biochemical recurrent disease is defined as an increase in the serum value of prostate-specific antigen (PSA) after reaching the nadir. Prostate recurrence can present as PSA-only relapse, local recurrent disease, distant metastases, or a combination of local and distant recurrence. In this review, the role of magnetic resonance imaging in the work-up of recurrent prostate cancer is discussed.
Upload full text
Use your RU credentials (u/z-number and password) tolog in with SURFconextto upload a file for processing by the repository team.